
Amr El-Refaey/LinkedIn
Aug 16, 2025, 11:45
Amr El-Refaey: IQVIA Report Highlights Oncology Therapy Access in MEA
Amr El-Refaey, Medical Affairs and New Therapy Areas Lead at the Globalpharma LLC, shared a post on LinkedIn:
“IQVIA Report, August 2025!
Oncology Therapy Access in the Era of Personalized Medicine!
Trends in Regulatory Approval and Reimbursement for Select Countries in the Middle East and Africa!”
Read the full report.
More posts about IQVA on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 16, 2025, 21:51
Aug 16, 2025, 21:38
Aug 16, 2025, 21:05
Aug 16, 2025, 20:40
Aug 16, 2025, 20:27
Aug 16, 2025, 20:22